T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice - Test2 - elhamkhani - TriplyDB

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

http://www.wikidata.org/entity/Q24603574

about

Tuberculosis and HIV co-infection Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice Targeted DNA mutagenesis for the cure of chronic viral infections The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic Animal Models for HIV Cure Research Targeting Th17 Cells with Small Molecules and Small Interference RNA Animal models to study Mycobacterium tuberculosis and HIV co-infection Studies of retroviral infection in humanized mice The involvement of microRNAs in neurodegenerative diseases Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives Recent developments in human immunodeficiency virus-1 latency research New generation humanized mice for virus research: comparative aspects and future prospects Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized mice Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.Silencing Viral MicroRNA as a Novel Antiviral Therapy?Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Knocking down disease: a progress report on siRNA therapeutics Current prospects for RNA interference-based therapies Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro Animal models for HIV/AIDS research Closing the door to human immunodeficiency virus.Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to b cells in vitro and in vivo.Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology Human allograft rejection in humanized mice: a historical perspective Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA.Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.Drug delivery-mediated control of RNA immunostimulation Versatile RNA interference nanoplatform for systemic delivery of RNAs.Aptamer-targeted cell-specific RNA interference Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice

P2860

Q21131403-BC55CD72-F296-4AF4-8487-40235A65D03C Q21133769-2DB26583-6D75-4DEF-9811-90C80B5A577C Q24620150-7A2B2D3A-7550-4B39-9D3D-64D190C98036 Q24655011-1EE11F8A-4EF6-4CCA-AB0F-C6A3D66CEBDE Q26767476-04DDBA84-59C2-448E-A870-F0B655DACDF8 Q26770523-46D54C2A-48A6-4C45-BFFA-F01680E38FFC Q26824653-DC54A694-55BE-4198-BACD-4D316D923A1B Q26849806-764EAD7D-54B1-4A8C-A87F-84857CD0B98B Q26858788-FBE4963D-1B2F-466E-9C60-C7230DA779A9 Q26859021-DF262D46-41A5-4225-8A12-1741E6E67A14 Q27013114-FB37DFEF-A4FB-404C-8ADC-8921B07FBABA Q27014786-0CC88E3B-1D14-4360-B913-9EF50F5393EB Q27022347-B6A2FCD3-08CF-43FD-80DC-B9685D463626 Q27318674-175CEE62-C3A9-4E98-BD67-FAD20CA877A9 Q27488437-38EB4872-93F2-4AB1-B5FB-4E23910A6D18 Q27490919-E8F87236-1299-450F-9F35-E1DBD5B0FF30 Q27692125-5612510B-1834-405B-B4C6-953EFB98A8B8 Q28082939-748FA255-8AF9-4855-AD6D-03D0BD8EF5DA Q28235733-8CBA7E2A-0461-4D31-9517-FCD3E5D95541 Q28538875-4F799004-7946-46A8-914F-FEB3889BDA42 Q28728917-2C9E2D36-D3FF-4C55-91FF-B8E4A8E8696A Q30423656-44CCE33D-8FA3-441E-BEF5-80D9895A2D63 Q30428089-B55254AE-15F0-4433-9BCF-5F155A9E7BFF Q30531035-74CFE68E-AF35-4897-B5CA-545DA1CE920B Q30825112-0AE54210-AA47-4DC6-A403-7C9797467B86 Q33540178-A654CBC6-6AF5-4A86-A495-61AAB510564E Q33577374-BAD5691D-358F-41F3-969A-6A13899A9E42 Q33622741-14AFBB4C-58AC-4448-ABE2-8D723604337A Q33676640-B67E358A-6054-49DA-8565-F74E35B238A6 Q33686536-5E59595C-4343-429A-8D35-A07186376D34 Q33687594-57ACE3D0-AB43-4D3F-8F93-F53495942648 Q33697336-42B48C1A-C784-45E2-A6D5-D1081DC313F0 Q33701022-B7BB88A0-9C60-4026-8DA7-9B6A050D3E63 Q33713713-777C28EE-74E9-4385-BF20-74899E42C1D0 Q33713938-65D5E60E-D254-4432-B59E-C06C18DA422E Q33716038-B1FE82DA-0F4F-4481-9E00-CBAB7E37BF35 Q33717239-A5C5F64F-A5F9-430F-B350-67930A76CC5B Q33719287-BF85CA9A-81B0-4AE1-A581-4A57DD5EEB94 Q33730481-C498AA47-86FD-4172-A987-3B809F5D9DDD Q33730699-8B94AD84-B135-40B2-A51C-072AB274388D

P2860

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

http://www.wikidata.org/entity/Q24603574

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@ast

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@en

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@nl

type

label

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@ast

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@en

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@nl

prefLabel

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@ast

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@en

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@nl

P1433

Q24603574-3851BA76-5280-4379-8073-96D988BD56BF

P1476

Q24603574-1E78FCFC-8A2B-469A-8859-76CA13AA2BC5

P2093

Q24603574-10A17E28-A104-4D30-85B2-A469FC64264D

Q24603574-118A4490-9A21-452E-AC20-30B545BD06A4

Q24603574-174AAF38-9E01-4F0D-B503-CB1DD4D30E8C

Q24603574-25A8276F-9298-43C3-878B-B7933BD372EF

Q24603574-27883FDF-3D2A-41C9-9894-932032FBE2F2

Q24603574-2CC8B79D-D1AB-4C51-ADB8-00A2B75E40D7

Q24603574-340FBD51-05E0-4FED-9A40-E9C5DDD1D6F0

Q24603574-38517AA1-82FA-41D9-A8DA-BA470144764B

Q24603574-574C802F-C278-4D55-A928-EB4326C25F75

Q24603574-6AA73771-E9D8-4495-8AD9-F7D179179292

P2860

Q24603574-0306DA91-F7C1-4533-9715-536F2FD3F0B4

Q24603574-117C6CF9-BBBB-4F0F-97CD-CE89041AF69D

Q24603574-12358CAC-EA5F-4CE4-8B8D-7D7117539BBE

Q24603574-13C04537-671B-4EAF-83D6-CBDCE50B118A

Q24603574-23FB5F50-0B9B-4F9B-BDA2-C98DCAE1D6FD

Q24603574-24ACA14F-8D56-48DC-BA62-50A131B5D8E4

Q24603574-2C31D229-9B89-49F0-B482-308EB23459D3

Q24603574-2DD7DFB5-E3CC-49EA-9BAD-55C13E4678D0

Q24603574-30DA3F0D-3640-4D2E-B653-149BD5F36271

Q24603574-36EB4150-8AA5-4041-818E-8FF0CE4861FF

P304

Q24603574-1A468640-007C-4797-B239-BB0618ADC7CE

P31

Q24603574-94681788-E3FB-4E61-8FB4-BAB2235BDE1C

P3181

Q24603574-ED706D1C-40DC-4DB6-9B69-54848D4DE89C

P356

Q24603574-3F22BDD3-2896-4614-870F-3BF1F8105767

P407

Q24603574-A2B089C2-A525-4689-9CF0-68BDCB537DCC

P433

Q24603574-C37AC756-26D9-483A-B93F-CC3EA3178EEB

P478

Q24603574-9D4CA9D0-F34E-445A-BA72-A6CFC8CC2985

P577

Q24603574-61F8768A-2F5B-4E0C-8E10-F7F051166743

P5875

Q24603574-8A489B8E-4574-454D-81F1-22C255A21981

P698

Q24603574-C64C3FF1-FE2C-4DEB-BCB8-C6C4B84B2319

P932

Q24603574-3A0F10F5-CDFB-4C88-9793-2AAEFC36195E

P3181

P356

J.CELL.2008.06.034

P1433

P1476

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

@en

P2093

Amale Laouar

http://www.w3.org/2001/XMLSchema#string

Dale L Greiner

http://www.w3.org/2001/XMLSchema#string

Georg H Fey

http://www.w3.org/2001/XMLSchema#string

Haoquan Wu

http://www.w3.org/2001/XMLSchema#string

Hong-Seok Ban

http://www.w3.org/2001/XMLSchema#string

Ji-Hoon Jeong

http://www.w3.org/2001/XMLSchema#string

Jiahong Yao

http://www.w3.org/2001/XMLSchema#string

Katsuyoshi Habiro

http://www.w3.org/2001/XMLSchema#string

Kuen-Yong Lee

http://www.w3.org/2001/XMLSchema#string

Leonard D Shultz

http://www.w3.org/2001/XMLSchema#string

P2860

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

Gene transfer in humans using a conditionally replicating lentiviral vector

Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb

miRNA profiling of naïve, effector and memory CD8 T cells.

Can the new humanized mouse model give HIV research a boost

Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.

Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.

P304

577-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4899622

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELL.2008.06.034

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23160423

http://www.w3.org/2001/XMLSchema#string

P698

18691745

http://www.w3.org/2001/XMLSchema#string

P932

2943428

http://www.w3.org/2001/XMLSchema#string